Paradigm Biopharmaceuticals Limited
ASX:PAR.AX
0.42 (AUD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.066 | 0 | 0.042 | 0.005 | 0.034 | 0.045 | 0.021 | 0 | -0.826 | 0.826 | 2.956 | 0.028 | 2.66 | 0.022 | 1.766 | 0.058 | 1.244 | 0.046 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.009 | 0.073 | 0.088 | 0.084 | 0.169 | 0.168 | 0.206 | 0.103 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.057 | -0.073 | -0.046 | -0.08 | -0.135 | -0.122 | -0.185 | -0.103 | -0.826 | 0.826 | 2.956 | 0.028 | 2.66 | 0.022 | 1.766 | 0.058 | 1.244 | 0.046 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.863 | 0 | -1.098 | -16.89 | -3.981 | -2.706 | -9.025 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 11.959 | 46.374 | 24.949 | 27.73 | 15.562 | 23.45 | 16.322 | 17.195 | 8.478 | 4.316 | 4.708 | 3.188 | 3.886 | 2.708 | 2.517 | 1.716 | 1.936 | 0.932 | 0.129 | 0.029 | 0 | 0 |
| General & Administrative Expenses
| 2.697 | 3.519 | 2.001 | 4.563 | 4.154 | 3.781 | 5.097 | 3.652 | 1.34 | 1.6 | 0.725 | 0.747 | 0.761 | 0.523 | 0.464 | 0.837 | 0.445 | 0.305 | 0.05 | 0.17 | 0.116 | 0.116 |
| Selling & Marketing Expenses
| 0.3 | 0.253 | 0.36 | 0.462 | 0.499 | 0.42 | 0.717 | 0.119 | 1.227 | 0 | 1.869 | 0.493 | 0.625 | 0.365 | 0.268 | 0.323 | 0.443 | 0.231 | 0.784 | 0.411 | 0 | 0 |
| SG&A
| 2.997 | 3.446 | 1.924 | 4.487 | 4.057 | 3.684 | 4.99 | 3.548 | 2.567 | 1.6 | 2.807 | 1.24 | 1.386 | 0.887 | 0.732 | 1.16 | 0.888 | 0.537 | 0.834 | 0.581 | 0.116 | 0.116 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 14.957 | 49.82 | 26.874 | 32.216 | 19.62 | 27.133 | 21.312 | 20.743 | 11.044 | 5.916 | 7.516 | 4.428 | 5.331 | 3.596 | 3.248 | 2.876 | 2.85 | 1.469 | 0.962 | 0.61 | 0.116 | 0.116 |
| Operating Income
| -14.966 | -49.893 | -26.92 | -32.296 | -19.755 | -27.256 | -21.497 | -20.847 | -11.044 | -5.916 | -7.516 | -4.4 | -2.671 | -3.573 | -1.483 | -2.818 | -1.605 | -1.423 | -0.962 | -0.61 | -0.116 | -0.116 |
| Operating Income Ratio
| -227.439 | 0 | -640.19 | -6,856.864 | -580.621 | -603.001 | -1,046.084 | 0 | 13.372 | -7.162 | -2.543 | -156.371 | -1.004 | -159.984 | -0.84 | -48.918 | -1.29 | -30.861 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.285 | -0.126 | 0.611 | -0.347 | 7.491 | 0.271 | 7.93 | 0.116 | 4.675 | -0.014 | -6.88 | 0 | -0.004 | 0 | 0.026 | 0 | 0.078 | 0 | 0.002 | 0.005 | 0 | 0 |
| Income Before Tax
| -14.681 | -50.02 | -26.309 | -32.643 | -12.265 | -26.985 | -13.567 | -20.73 | -7.195 | -5.104 | -11.227 | -4.4 | -2.617 | -3.573 | -1.457 | -2.818 | -1.502 | -1.423 | -0.96 | -0.605 | -0.116 | -0.116 |
| Income Before Tax Ratio
| -223.112 | 0 | -625.657 | -6,930.641 | -360.468 | -597.014 | -660.18 | 0 | 8.711 | -6.18 | -3.798 | -156.371 | -0.984 | -159.984 | -0.825 | -48.918 | -1.207 | -30.861 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -4.986 | -1.061 | -6.266 | -0.776 | -0 | 0 | 0 | -0 | -0.826 | 0.826 | 2.956 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0.005 | 0 | 0 |
| Net Income
| -9.695 | -48.958 | -20.043 | -31.867 | -12.265 | -26.985 | -13.567 | -20.73 | -7.195 | -5.104 | -11.227 | -4.4 | -2.617 | -3.573 | -1.457 | -2.818 | -1.502 | -1.423 | -0.96 | -0.605 | -0.116 | -0.116 |
| Net Income Ratio
| -147.337 | 0 | -476.637 | -6,765.908 | -360.468 | -597.014 | -660.18 | 0 | 8.711 | -6.18 | -3.798 | -156.371 | -0.984 | -159.984 | -0.825 | -48.918 | -1.207 | -30.861 | 0 | 0 | 0 | 0 |
| EPS
| -0.034 | -0.16 | -0.069 | -0.12 | -0.051 | -0.11 | -0.057 | -0.088 | -0.034 | -0.026 | -0.075 | -0.034 | -0.025 | -0.03 | -0.014 | -0.031 | -0.018 | -0.019 | -0.019 | -0.037 | 0 | 0 |
| EPS Diluted
| -0.034 | -0.16 | -0.069 | -0.12 | -0.051 | -0.11 | -0.057 | -0.088 | -0.034 | -0.026 | -0.075 | -0.034 | -0.025 | -0.03 | -0.014 | -0.031 | -0.018 | -0.019 | -0.019 | -0.037 | 0 | 0 |
| EBITDA
| -14.892 | -50.073 | -27.25 | -32.681 | -20.158 | -27.579 | -13.441 | -20.863 | -11.865 | -5.017 | -4.554 | -4.398 | -2.664 | -3.565 | -1.467 | -2.817 | -1.603 | -1.422 | 0.002 | 0.005 | 0 | 0 |
| EBITDA Ratio
| -226.325 | 0 | -638.364 | -6,840.537 | -577.788 | -600.858 | -1,040.883 | 0 | 14.365 | -6.074 | -1.541 | -156.298 | -1.001 | -159.612 | -0.831 | -48.896 | -1.288 | -30.85 | 0 | 0 | 0 | 0 |